Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SORT OUT XII DAPT Duration Trial
2024-515236-69-00Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel in acute coronary syndrome (ACS) (2 arms), sponsored by University Hospital Odense. Primary endpoints: Clinically relevant bleeding (BARC 2, 3 and 5) and Composite major adverse cardiovascular or cerebrovascular events (MACCE). Started Aug 2024; status: completed.
02
Drugs
prasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2024-515236-69-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515236-69-00.